T 1241/03 (Human growth hormone/GENENTECH) of 1.9.2005

European Case Law Identifier: ECLI:EP:BA:2005:T124103.20050901
Date of decision: 01 September 2005
Case number: T 1241/03
Application number: 93918499.0
IPC class: A61K 38/27
A61K 47/10
A61K 47/26
Language of proceedings: EN
Distribution: C
Download and more information:
Decision text in EN (PDF, 92 KB)
Documentation of the appeal procedure can be found in the Register
Bibliographic information is available in: EN
Versions: Unpublished
Title of application: Human growth hormone aqueous formulation
Applicant name: GENENTECH, INC.
Opponent name: 01. Grandis Biotech GmbH
02. Novo Nordisk A/S
Board: 3.3.04
Headnote: -
Relevant legal provisions:
European Patent Convention 1973 Art 56
European Patent Convention 1973 Art 83
European Patent Convention 1973 Art 123(2)
Keywords: Main request, auxiliary requests 1 and 4 - sufficiency of disclosure (no)
Auxiliary request 2 - admissibility (no)
Auxiliary request 3 - inventive step (no)
Ultimate claim request - added subject-matter (no), sufficiency, novelty, inventive step (yes)
Catchwords:

-

Cited decisions:
G 0001/03
T 0252/85
T 0665/90
T 0409/91
T 0522/91
T 0759/91
T 0149/93
T 0333/97
T 1045/98
T 0190/99
T 0388/99
T 1126/00
T 1098/01
Citing decisions:
T 0666/05
T 0723/05
T 1599/06
T 0499/09
T 1992/11
T 2485/11
T 1259/16
T 0347/17

Source: http://www.epo.org/law-practice/case-law-appeals/recent/t031241eu1.html

Date retrieved: 17 May 2021

16 references found.

Click X to load a reference inside the current page, click on the title to open in a new page.

Case Law Book: I Patentability

Case Law Book: II Conditions to be met by an Application

Case Law of the Enlarged Board

General Case Law